Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis

Radiation Research

Volumn 175, Issue 5, 2011, Pages 547-560

  Chiu, Hui Wen ^a   Lin, Wei ^a   Ho, Sheng Yow ^b   Wang, Ying Jan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN SIN LAU HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CATALASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SURVIVAL; COMET ASSAY; CYTOTOXICITY; DNA DAMAGE; DRUG ACTIVITY; HUMAN; HUMAN CELL; IONIZING RADIATION; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; AUTOPHAGY; CATALASE; CELL LINE, TUMOR; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; OSTEOSARCOMA; OXIDES; POLYETHYLENE GLYCOLS;

EID: 79955416811     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2380.1     Document Type: Article

References (61)

1. J. Taki, H. Sumiya, T. Higuchi, H. Tsuchiya, K. Takazawa, K. Tomita and N. Tonami, Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial 99mTcmacroaggregated albumin administration in patients with bone and soft-tissue tumors. J. Nucl. Med. 43, 1452-1456 (2002). (Pubitemid 35285869)
2. X. Xie, K. D. S. Yang, Z. M. Ye and H. M. Tao, Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines. Chemotherapy 55, 433-440 (2009).
3. P. A. Meyers, R. Gorlick, G. Heller, E. Casper, J. Lane, A. G. Huvos and J. H. Healey, Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J. Clin. Oncol. 16, 2452-2458 (1998).
4. K. H. Antman, Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6, 1-2 (2001). (Pubitemid 32405842)
5. X. H. Zhu, Y. L. Shen, Y. K. Jing, X. Cai, P. M. Jia, Y. Huang, W. Tang, G. Y. Shi and Y. P. Sun, Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 91, 772-778 (1999). (Pubitemid 29239056)
6. Y. H. Kang and S. J. Lee, Role of p38 MAPK and JNK in enhanced cervical cancer cell killing by the combination of arsenic trioxide and ionizing radiation. Oncol. Rep. 20, 637-643 (2008).
7. H. W. Chiu, S. Y. Ho, H. R. Guo and Y. J. Wang, Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways. Autophagy 5, 472-83 (2009).
8. H. W. Chiu, J. H. Lin, Y. A. Chen, S. Y. Ho and Y. J. Wang, Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis. Autophagy 6, 353-365 (2010).
9. S. Turcotte and A. J. Giaccia, Targeting cancer cells through autophagy for anticancer therapy. Curr. Opin. Cell Biol. 22, 246- 251 (2010).
10. A. Apel, H. Zentgraf, M. W. Buchler and I. Herr, Autophagy - A double-edged sword in oncology. Int. J. Cancer 125, 991-995 (2009).
11. M. Kundu and C. B. Thompson, Autophagy: basic principles and relevance to disease. Annu. Rev. Pathol. 3, 427-455 (2008). (Pubitemid 351488288)
12. Y. Sun and Z. L. Peng, Programmed cell death and cancer. Postgrad. Med. J. 85, 134-140 (2009).
13. R. Mathew, V. Karantza-Wadsworth and E. White, Role of autophagy in cancer. Nat. Rev. Cancer 7, 961-967 (2007). (Pubitemid 350165856)
14. J. Wang, L. Yang, J. Yang, K. Kuropatwinski, W. Wang, X. Q. Liu, J. Hauser and M. G. Brattain, Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res. 68, 3152-3160 (2008).
15. Y. Kondo, T. Kanzawa, R. Sawaya and S. Kondo, The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 5, 726-734 (2005). (Pubitemid 41486365)
16. M. Hoyer-Hansen, L. Bastholm, I. S. Mathiasen, F. Elling and M. Jaattela, Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ. 12, 1297-1309 (2005). (Pubitemid 41486100)
17. W. Qian, J. Liu, J. Jin, W. Ni and W. Xu, Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk. Res. 31, 329-339 (2007). (Pubitemid 46073178)
18. K. F. Hsu, C. L.Wu, S. C. Huang, C. M. Wu, J. R. Hsiao, Y. T. Yo, Y. H. Chen, A. L. Shiau and C. Y. Chou, Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy 5, 451-460 (2009).
19. S. Burdak-Rothkamm and K. M. Prise, New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells. Eur. J. Pharmacol. 625, 151-155 (2009).
20. H. R. Withers, K. Mason, B. O. Reid, N. Dubravsky, H. T. Barkley, Jr., B. W. Brown and J. B. Smathers, Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle. Cancer 34, 39-47 (1974).
21. S. Y. Ho, W. C. Chen, H. W. Chiu, C. S. Lai, H. R. Guo and Y. J. Wang, Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation. Chem. Biol. Interact. 179, 304-313 (2009).
22. Y. J. Chun, I. C. Park, M. J. Park, S. H. Woo, S. I. Hong, H. Y. Chung, T. H. Kim, Y. S. Lee and C. H. Rhee, Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3). FEBS Lett. 519, 195-200 (2002). (Pubitemid 34522018)
23. L. N. Su and J. B. Little, Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat. Res. 133, 73-79 (1993). (Pubitemid 23070028)
24. S. Ning and S. J. Knox, Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Int. J. Radiat. Oncol. Biol. Phys. 60, 197-203 (2004). (Pubitemid 39165485)
25. D. C. Ma, Y. H. Sun, K. Z. Chang, X. F. Ma, S. L. Huang, Y. H. Bai, J. Kang, Y. G. Liu and J. J. Chu, Selective induction of apoptosis of NB4 cells from G2zM phase by sodium arsenite at lower doses. Eur. J. Haematol. 61, 27-35 (1998). (Pubitemid 28326400)
26. M. J. McCabe, Jr., K. P. Singh, S. A. Reddy, B. Chelladurai, J. G. Pounds, J. J. Reiners, Jr. and J. C. States, Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase. J. Pharmacol. Exp. Ther. 295, 724-733 (2000).
27. T. C. Chou and P. Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27-55 (1984).
28. P. L. Peng, W. H. Kuo, H. C. Tseng and F. P. Chou, Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int. J. Radiat. Oncol. Biol. Phys. 70, 529-542 (2008).
29. D. G. McArt, G. McKerr, K. Saetzler, C. V. Howard, C. S. Downes and G. R. Wasson, Comet sensitivity in assessing DNA damage and repair in different cell cycle stages. Mutagenesis 25, 299-303 (2010).
30. T. J. McDonnell, R. E. Meyn and L. E. Robertson, Implications of apoptotic cell death regulation in cancer therapy. Semin. Cancer Biol. 6, 53-60 (1995).
31. S. Paglin, T. Hollister, T. Delohery, N. Hackett, M. McMahill, E. Sphicas, D. Domingo and J. Yahalom, A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61, 439-444 (2001). (Pubitemid 32128593)
32. G. Bjorkoy, T. Lamark, A. Brech, H. Outzen, M. Perander, A. Overvatn, H. Stenmark and T. Johansen, p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603-614 (2005). (Pubitemid 41668720)
33. K. W. Kim, M. Hwang, L. Moretti, J. J. Jaboin, Y. I. Cha and B. Lu, Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4, 659-668 (2008).
34. W. Zhuang, Z. Qin and Z. Liang, The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim. Biophys. Sin. (Shanghai) 41, 341-351 (2009).
35. M. Verheij, C. Vens and B. van Triest, Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective. Drug Resist. Updat. 3, 29-43 (2010).
36. H. S. Pandha, L. Heinemann, G. R. Simpson, A. Melcher, R. Prestwich, F. Errington, M. Coffey, K. J. Harrington and R. Morgan, Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma. Clin. Cancer Res. 15, 6158-6166 (2009).
37. S. Y. Ho, P. C. Huang, H. R. Guo, W. H. Chang, R. J. Chen, B. L. Wei, W. J. Wu, C. Tai and Y. J. Wang, Mechanisms of apoptosis induction and cell cycle regulation in irradiated leukemia U937 cells and enhancement by arsenic trioxide. Radiat. Res. 165, 390-399 (2006).
38. H. Zhang, X. Kong, J. Kang, J. Su, Y. Li, J. Zhong and L. Sun, Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol. Sci. 110, 376-388 (2009).
39. T. Shintani and D. J. Klionsky, Autophagy in health and disease: a double-edged sword. Science 306, 990-995 (2004). (Pubitemid 39482894)
40. M. C. Maiuri, E. Zalckvar, A. Kimchi and G. Kroemer, Selfeating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8, 741-752 (2007). (Pubitemid 47312826)
41. A. Bommareddy, E. R. Hahm, D. Xiao, A. A. Powolny, A. L. Fisher, Y. Jiang and S. V. Singh, Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res. 69, 3704-3712 (2009).
42. B. Y. Law, M. Wang, D. L. Ma, F. Al-Mousa, F. Michelangeli, S. H. Cheng, M. H. Ng, K. F. To, A. Y. Mok and B. C. Ko, Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2z ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis. Mol. Cancer Ther. 9, 718-730 (2010).
43. Z. H. Wang, L. Xu, Z. L. Duan, L. Q. Zeng, N. H. Yan and Z. L. Peng, Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol. Oncol. 107, 107-113 (2007). (Pubitemid 47495947)
44. D. Branzei and M. Foiani, Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol. 9, 297-308 (2008). (Pubitemid 351430844)
45. K. Higginbottom, U. Jahnke, A. C. Newland, F. E. Cotter and P. D. Allen, New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposideinduced apoptosis. Apoptosis 12, 1847-1855 (2007). (Pubitemid 47498240)
46. Y. Matsui, H. Takagi, X. Qu, M. Abdellatif, H. Sakoda, T. Asano, B. Levine and J. Sadoshima, Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMPactivated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100, 914-922 (2007). (Pubitemid 46555697)
47. E. Vorotnikova, R. A. Rosenthal, M. Tries, S. R. Doctrow and S. J. Braunhut, Novel synthetic SOD/catalase mimetics can mitigate capillary endothelial cell apoptosis caused by ionizing radiation. Radiat. Res. 173, 748-759 (2010).
48. R. A. Lockshin and Z. Zakeri, Apoptosis, autophagy, and more. Int. J. Biochem. Cell Biol. 36, 2405-2419 (2004). (Pubitemid 39119755)
49. B. Liu, Y. Cheng, B. Zhang, H. J. Bian and J. K. Bao, Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondriamediated ROS-p38-p53 pathway. Cancer Lett. 275, 54-60 (2009).
50. N. Bitomsky and T. G. Hofmann, Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2. FEBS J. 276, 6074-6083 (2009).
51. J. Bartek, J. Bartkova and J. Lukas, DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26, 7773-7779 (2007). (Pubitemid 350242463)
52. D. Koul, R. Shen, Y. W. Kim, Y. Kondo, Y. Lu, J. Bankson, S. M. Ronen, D. L. Kirkpatrick and G. Powis, Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. Neuro. Oncol. 12, 559-565 (2010).
53. B. T. Hennessy, D. L. Smith, P. T. Ram, Y. Lu and G. B. Mills, Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988-1004 (2005).
54. P. Watcharasit, A. Thiantanawat and J. Satayavivad, GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J. Appl. Toxicol. 28, 466-474 (2008). (Pubitemid 351716531)
55. D. D. Sarbassov, D. A. Guertin, S. M. Ali and D. M. Sabatini, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005). (Pubitemid 40262113)
56. J. A. McCubrey, M. M. Lahair and R. A. Franklin, OSU-03012 in the treatment of glioblastoma. Mol. Pharmacol. 70, 437-439 (2006). (Pubitemid 44092301)
57. H. Takeuchi, Y. Kondo, K. Fujiwara, T. Kanzawa, H. Aoki, G. B. Mills and S. Kondo, Synergistic augmentation of rapamycininduced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 65, 3336-3346 (2005). (Pubitemid 40524618)
58. Y. Nakamura, S. Yogosawa, Y. Izutani, H. Watanabe, E. Otsuji and T. Sakai, A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol. Cancer 8, 100 (2009).
59. P. Kumar, Q. Gao, Y. Ning, Z.Wang, P. H. Krebsbach and P. J. Polverini, Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone. Mol. Cancer Ther. 7, 2060-2069 (2008).
60. N. Green, S. French, G. Rodriquez, M. Hays and A. Fingerhut, Radiation-induced delayed union of fractures. Radiology 93, 635-641 (1969).
61. B. A. Jereczek-Fossa and R. Orecchia, Radiotherapy-induced mandibular bone complications. Cancer Treat. Rev. 28, 65-74 (2002). (Pubitemid 34679209)